CXCR4/CXCL12 Axis in Non Small Cell Lung Cancer (NSCLC) Pathologic Roles and Therapeutic Potential

Theranostics - Canada
doi 10.7150/thno.4922
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ivyspring International Publisher

Related search

Hmgb1: A Potential Therapeutic Target for Non-Small Cell Lung Cancer

Lettters in Health & Biological Sciences
2016English

Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)

Open Access Journal of Oncology and Medicine
2018English

Caspase Regulation in Non-Small Cell Lung Cancer and Its Potential for Therapeutic Exploitation

Clinical Cancer Research
Cancer ResearchOncology
2005English

Gemcitabine in Non-Small Cell Lung Cancer (NSCLC): The Evidence of Its Therapeutic Value in Molecular Age

Clinical Medicine Reviews in Oncology
2010English

Emerging Targets in Cancer Management: Role of the CXCL12/CXCR4 Axis

OncoTargets and Therapy
OncologyPharmacology
2013English

P2.01-129 Potential Impact of KRAS Molecular Profiling of Non-Squamous Non-Small Cell Lung Cancer (NSCLC).

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Pcn120 - Epidemiology and Costs of Non-Small Cell Lung Cancer (Nsclc) in Austria

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

PCN134 Patient Preferences for Non-Small Cell Lung Cancer (NSCLC) Treatments

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Emerging Roles of Nrf2 Signal in Non-Small Cell Lung Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy